Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Assuming the idea there is that generics will not have enough supply to keep up
Judging by your prior posts I think i’ll change the channel now...
6 cents on 39k shares ? Must be a buyout.
But his friend of a friend of a friend knows Thero!
Judge Dyk is that you?
Excellent post sir
Good catch, wonder what the heck that’s all about...
Interesting , good find. Lets hope it means what we want it to mean.
How do you know this? Source ?
To the business minds on the board—
If Amarin were to be acquired, is there any benefit for the parent organization to allow Amarin to continue to operate as it’s own entity ?
I’ve had similar thoughts over the past couple months. When does Wall Street acknowledge this? Michael Yee isn’t sharp enough to see this unraveling ?
I believe JT has made the tacked on exclusivity seem like a relatively sure thing. So I would imagine that would either be priced in (depending on the level of certainty) or simply attached as a CVR to the deal.
BP isn’t capable of handling the exclusivity extension on their own?
Let’s wait for the court decisions.
Let’s wait for the Alzheimer’s study.
Let’s wait for the cancer study to read out.
Let’s wait to see if Amarin can put an end to this pandemic.
Gilead/Nash?
Not directing this message towards you, but by the time all of this pans out i’ll have died from old age and i’m 26. I firmly believe if AMRN actually launches this drug in Europe it is much less likely to be acquired.
FYI our new fearless leader is Karim Mikhail, not Mikhail Karim.
Understood, thanks!
When are we expecting an update for this case ?
He posts because the satisfaction of “I told you so” over a largely anonymous forum really gets his juices flowing.
Marjac,
Regardless of the outcome, thank you so so so much for your heroic efforts.
I’m wondering if you have had to buy replacement keys for the B and P on your keyboard yet.
Just joking— I share the same frustrations. Drug absolutely belongs in the hands of the big boys.
I think it’s less about the timing of the launch and more about the very real possibility there is no takeover. Anyone who wants to watch AMRN GIA is out of their mind. I refuse to believe BP will allow Amarin to set the stage in EU and then come in and take over a few months down the road. If anyone disagrees with that logic, i’m all ears...
They announced it yesterday and it was so brutal that the poster deleted his message within an hour or so.
Holy crap. How in the world did that email leak?
Lmfao
Understood. Hope I am wrong! Very ready for some great news.
That guy spews non sense all over stock twits. Wouldn’t put too much faith into whatever he has to say.
Pretty light in comparison to last months
I’m feeling the same way. That website is a total joke.
I cannot see BP allowing Amarin to launch in Europe if there is serious interest in acquiring this company. BP would HAVE to want to hit the ground running.
With a cost basis around $9 I think by 2023 I may break even with GIA strategy, barring some type of legal miracle. Not worth it.
Should we be expecting another motion to dismiss ?
Can you paraphrase?
It’s “seaked” , not weekend ;)
Are you on statin?
No worries. I think we were all having trouble interpreting the formulary.
Fingers crossed. We are due for a break.
Surprised this isn’t attracting more attention here. If I understand this correctly, this is pretty big news...
Maybe I would have agreed with you had the price been floating around the 8-9 range like it was when we received CHMP opinion. Now? How could it be priced in at 5.70?
Great work zman
You know the drill, forward to IR.
Newman was so so impressive. Her voice sounded frail but she is still as sharp as a tack. God Bless that woman.